Blood Serum From Head and Neck Squamous Cell Carcinoma Patients Induces Altered MicroRNA and Target Gene Expression Profile in Treated Cells

The head and neck squamous cell carcinoma (HNSCC) represents one of the most common cancers in humans. Close to 600,000 new diagnoses are made every year worldwide and over half of diagnosed patients will not survive. In view of this low survival rate, the development of novel cell-based assays for...

Descripción completa

Detalles Bibliográficos
Autores principales: Allen, Brittany, Schneider, Augusto, Victoria, Berta, Nunez Lopez, Yury O., Muller, Mark, Szewczyk, Mateusz, Pazdrowski, Jakub, Majchrzak, Ewa, Barczak, Wojciech, Golusinski, Wojciech, Golusinski, Pawel, Masternak, Michal M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6004400/
https://www.ncbi.nlm.nih.gov/pubmed/29942793
http://dx.doi.org/10.3389/fonc.2018.00217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6004400/
https://www.ncbi.nlm.nih.gov/pubmed/29942793
http://dx.doi.org/10.3389/fonc.2018.00217

Ejemplares similares